You are here
BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results
RALEIGH, N.C., Feb. 21, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients living with chronic pain, today announced that it will report its fourth quarter and full year 2018 financial results after the close of the U.S. financial markets on Thursday, March 14, 2019. The company will host a conference call at 4:30 PM Eastern Time to discuss the results and provide an update on business operations.
Thursday, February 21, 2019 - 07:45